Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis

Therefore, we have established a novel molecular mechanism by which Runx2 provides a chemoprotective role in OS, indicating that in conjunction to standard chemotherapy, targeting Runx2 may be a new therapeutic strategy for patients with OS.